rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    DXR
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Major Memphis Health System Expands BVA® Adoption to New Hospital Outpatient Site

      Daxor’s ezBVA Lab Diagnostic Service Delivers 24-hour Turnaround Under Established Reimbursement Pathways to Support Ambulatory Care Oak Ridge, TN, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced that a major Memphis health system has expanded its Blood Volume Analysis (BVA) program to an additional hospital campus, utilizing Daxor’s ezBVA Lab service to support outpatient clinic testing. The launch buil

      15h agoYahoo FinanceDXR
      Daxor launches blood volume analysis program in Kansas
      Nov 17Investing.comDXR
      Daxor Expands Midwest Footprint with Launch of ezBVA Lab Program at Premier Kansas Academic Medical Center

      Turnkey ezBVA Lab Model Removes Capital Barriers and Leverages Established Reimbursement to Drive Rapid Clinical Adoption. Oak Ridge, TN, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced the commercial launch of a new Blood Volume Analysis (BVA®) program at a leading academic medical center in Kansas, expanding the company’s Midwest footprint and accelerating adoption of its centralized diagnostic service

      Nov 17Yahoo FinanceDXR
      Daxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26
      Oct 15Yahoo FinanceDXR
      Daxor presents clinical data on blood volume analysis technology
      Oct 14Investing.comDXR
      Daxor to Showcase Blood Volume Analysis Platform at ASN Kidney Week 2026
      Oct 13Yahoo FinanceDXR
      Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026

      FDA 510(k)-cleared next-generation diagnostic platform delivers 3x faster results with 50% less blood, setting a new standard for data-driven heart failure management. Key Highlights: Commercial Acceleration: Daxor to feature its FDA-cleared, next-generation Blood Volume Analyzer (BVA™) designed for rapid clinical adoption across hospital systems and outpatient clinicsClinical Evidence: Independent clinical investigators to present two ePosters highlighting how BVA addresses volume derangements

      Oct 1Yahoo FinanceDXR
      Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference

      Oak Ridge, TN, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will participate in Lake Street's Tenth Annual Best Ideas Growth (BIG10) Conference in New York City, New York on Thursday, September 10th, 2026. Management will host one-on-one and small group meetings with investors. For more information about the event or questions about registration, interested pa

      Sep 8Yahoo FinanceDXR
      Daxor reports 16% kit sales growth, expands sales team
      Sep 1Investing.comDXR
      Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter

      Oak Ridge, TN, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update in a Letter to Shareholders from CEO and President Michael Feldschuh. Dear Valued Shareholders, “It’s still Day 1.” — Jeff BezosThat's exactly how we think about where Daxor stands today. Everything we have accomplished to date — the FDA clearance of our next-generation analyzer, our new patent, our c

      Sep 1Yahoo FinanceDXR

      This is the newest page. Registered accounts read further back.